Characteristic Overview of HIV Patients Receiving Antiretroviral Therapy
DOI:
https://doi.org/10.61841/aqhqxk12Keywords:
Antiretroviral (ARV) Therapy, HIV, Adherence, Knowledge, Health EducationAbstract
This study aims to describe the characteristics of patients with HIV who are undergoing antiretroviral therapy. The study is a quantitative descriptive study carried out in a community health center in Surabaya, East Java province, in February 2020. The population was HIV patients who had received antiretroviral therapy for more than one month. A sample of 35 respondents was recruited using purposive sampling. Data were collected using a questionnaire that had been tested for validity and reliability. Data were analyzed descriptively. The frequency distribution of 35 respondents was obtained, with respondents aged 26-35 years at 31.4%, male sex at 48.6%, married at 45.7%, high school education at 31.4%, employment at 65.7%, income less than 500,000 per month at 62.9%, ARV consumption for more than one year at 80% and 60% receiving a fixed-dose combination therapy, 77.1% having a good knowledge level and 71.4% showing good adherence and 57.1% demonstrating fewer methods in providing health education. Characteristics of HIV patients receiving antiretroviral therapy generally include low levels of education and income, but the level of knowledge about HIV disease and respondent adherence to ARVs was good. Low income does not reduce the patient's desire to continue treatment. Support from health workers in providing health education with appropriate methods is expected to increase patient knowledge so that they can commit to adherence with ARV medications.
Downloads
References
[1] L. L. Sabin et al., “Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders,” JAIDS J. Acquir. Immune Defic. Syndr., 2015.
[2] J. Barroso, N. M. Leblanc, and D. Flores, “It’s Not Just the Pills: A Qualitative Meta-Synthesis of HIV Antiretroviral Adherence Research,” J. Assoc. Nurses AIDS Care, vol. 28, no. 4, pp. 462–478, 2017.
[3] UN Joint Programme on HIV/AIDS (UNAIDS), “PEOPLE LIVING WITH HIV RECEIVING ART - AS OF
30 JUNE,” http://aidsinfo.unaids.org/, 2020. [Online]. Available: http://aidsinfo.unaids.org/.
[4] Kemenkes RI, “Kementerian Kesehatan Republik Indonesia,” Kementerian Kesehatan RI. p. 1, 2019.
[5] AVERT, “Global HIV and AIDS statistics | AVERT,” Avert. p. n. pag., 2017.
[6] World Health Organization, Consolidated Guidlines On The Use Of Antiretroviral Drugs For Treating and Preventing HIV Infection. 2016.
[7] M. S. Cohen et al., “Antiretroviral therapy for the prevention of HIV-1 transmission,” in New England Journal of Medicine, 2016.
[8] United Nations Joint Programme on HIV/AIDS (UNAIDS), “90-90-90 An ambitious treatment target to help end the AIDS epidemic,” United Nations, p. 40, 2014.
[9] T. Bvochora et al., “Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues,” PLoS One, vol. 14, no. 2, pp. 1–13, 2019.
[10] O. Omonaiye, S. Kusljic, P. Nicholson, M. Mohebbi, and E. Manias, “Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV,” Int. J. Infect. Dis., vol. 81, pp. 225–230, 2019.
[11] E. Movahed et al., “Antiretroviral Therapy Adherence Among People Living With HIV: Directed Content Analysis Based on Information-Motivation-Behavioral Skills Model,” Int. Q. Community Health Educ., p. 0272684X1985802, 2019.
[12] L. Ren et al., “A correlation analysis of HHV infection and its predictive factors in an HIV-seropositive population in Yunnan, China,” J. Med. Virol., vol. 92, no. 3, pp. 295–301, Mar. 2020.
[13] M. Misutarno, N. Nursalam, and T. Sukartini, “Analysis of Psychology, Social, and Immunity in HIV/AIDS Patients Who Had Been Worked as Migrant Indonesia Worker in East Java,” 2017.
[14] Dinas Kesehatan Surabaya, “Puskesmas,” 2020. [Online]. Available: http://dinkes.surabaya.go.id/portal/upt-dinas/puskesmas/.
[15] D. Bukenya, B. N. Mayanja, S. Nakamanya, R. Muhumuza, and J. Seeley, “What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda,” AIDS Res. Ther., vol. 16, no. 1, pp. 1–9, 2019.
[16] S. C. Mann and J. R. Castillo-Mancilla, “HIV, aging, and adherence: an update and future directions,” Curr. Opin. HIV AIDS, vol. 15, no. 2, pp. 134–141, Mar. 2020.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
